OTC Drugs Of Abuse Tests Need Not List Drugs Left Uncovered - Final Rule
This article was originally published in The Tan Sheet
Manufacturers of over-the-counter drugs of abuse tests are discouraged from listing drugs not covered by the test on product labeling, FDA explains in its final rule downclassifying OTC drugs of abuse test sample collection systems from Class III to Class I.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC